ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Nektar Therapeutics

Nektar Therapeutics (NKTR)

0,9283
-0,0127
(-1,35%)
Geschlossen 22 Dezember 10:00PM
0,9865
0,0582
(6,27%)
Nach Börsenschluss: 12:55AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,9865
Gebot
0,93
Fragen
2,50
Volumen
1.588.916
0,90 Tagesbereich 0,96
0,4608 52-Wochen-Bereich 1,928
Marktkapitalisierung
Handelsende
0,941
Handelsbeginn
0,96
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.463.283
VWAP
0,920932
Durchschnittliches Volumen (3 Mio.)
1.857.934
Ausgegebene Aktien
184.458.284
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,62
Gewinn pro Aktie (EPS)
-1,5
Erlöse
90,12M
Nettogewinn
-276,06M

Über Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama... Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Nektar Therapeutics is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NKTR. The last closing price for Nektar Therapeutics was US$0,94. Over the last year, Nektar Therapeutics shares have traded in a share price range of US$ 0,4608 to US$ 1,928.

Nektar Therapeutics currently has 184.458.284 shares in issue. The market capitalisation of Nektar Therapeutics is US$173,58 million. Nektar Therapeutics has a price to earnings ratio (PE ratio) of -0.62.

NKTR Neueste Nachrichten

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0135-1.3511.050.8915902290.98044818CS
4-0.0435-4.223300970871.031.210.8924047531.0342612CS
12-0.1535-13.46491228071.141.490.8918579341.17784649CS
26-0.1535-13.46491228071.141.51950.8914770151.21095942CS
520.5138108.6947323880.47271.9280.460816977711.16098121CS
156-12.5135-92.692592592613.515.9450.412627971262.43363729CS
260-20.7735-95.466452205921.76290.412621924656.32417643CS

NKTR - Frequently Asked Questions (FAQ)

What is the current Nektar Therapeutics share price?
The current share price of Nektar Therapeutics is US$ 0,9865
How many Nektar Therapeutics shares are in issue?
Nektar Therapeutics has 184.458.284 shares in issue
What is the market cap of Nektar Therapeutics?
The market capitalisation of Nektar Therapeutics is USD 173,58M
What is the 1 year trading range for Nektar Therapeutics share price?
Nektar Therapeutics has traded in the range of US$ 0,4608 to US$ 1,928 during the past year
What is the PE ratio of Nektar Therapeutics?
The price to earnings ratio of Nektar Therapeutics is -0,62
What is the cash to sales ratio of Nektar Therapeutics?
The cash to sales ratio of Nektar Therapeutics is 1,9
What is the reporting currency for Nektar Therapeutics?
Nektar Therapeutics reports financial results in USD
What is the latest annual turnover for Nektar Therapeutics?
The latest annual turnover of Nektar Therapeutics is USD 90,12M
What is the latest annual profit for Nektar Therapeutics?
The latest annual profit of Nektar Therapeutics is USD -276,06M
What is the registered address of Nektar Therapeutics?
The registered address for Nektar Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Nektar Therapeutics website address?
The website address for Nektar Therapeutics is www.nektar.com
Which industry sector does Nektar Therapeutics operate in?
Nektar Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock